OOIR: Observatory of International Research

Papers

(The median citation count of Asia-Pacific Journal of Clinical Oncology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
An inverse stage‐shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID‐19 pandemic	51
COVID‐19 vaccination rates, intent, and hesitancy in patients with solid organ and blood cancers: A multicenter study	24
Measuring financial toxicity in Australian cancer patients – Validation of the COmprehensive Score for financial Toxicity (FACT COST) measuring financial toxicity in Australian cancer patients	24
Incidence, mortality, survival, and disease burden of breast cancer in China compared to other developed countries	21
A systematic review of the barriers to implementing human papillomavirus vaccination programs in low‐ and middle‐income countries in the Asia‐Pacific	19
Overview of epidemiological characteristics, clinical features, and risk factors of gastric cancer in Asia‐Pacific region	17
Roles of Myc‐associated zinc finger protein in malignant tumors	15
Metabolic profiling analysis for clinical urine of colorectal cancer	13
Increased TOX expression concurrent with PD‐1, Tim‐3, and CD244 in T cells from patients with non‐Hodgkin lymphoma	13
Screening and surveillance for gastric cancer: Does family history play an important role in shaping our strategy?	13
Tripartite motif‐containing 54 promotes gastric cancer progression by upregulating K63‐linked ubiquitination of filamin C	12
Short‐term multimodal prehabilitation improves functional capacity for colorectal cancer patients prior to surgery	12
CDK4/6 inhibitor plus endocrine therapy for hormone receptor‐positive, HER2‐negative metastatic breast cancer: The new standard of care	11
Telmisartan attenuates human glioblastoma cells proliferation and oncogenicity by inducing the lipid oxidation	10
Clinicopathological features and prognosis of patients with pregnancy‐associated breast cancer: A matched case control study	10
Drug induced vitiligo‐like depigmentation from a CDK 4/6 inhibitor	10
Understanding mammographic breast density profile in China: A Sino‐Australian comparative study of breast density using real‐world data from cancer screening programs	9
miRNA‐31 increases radiosensitivity through targeting STK40 in colorectal cancer cells	9
Recommended testing algorithms for NTRK gene fusions in pediatric and selected adult cancers: Consensus of a Singapore Task Force	8
Advances and challenges of neoadjuvant therapy in pancreatic cancer	8
Association between financial toxicity and health‐related quality of life in cancer survivors: A systematic review	8
Poster Abstracts	8
Prognostic value of ASXL1 mutations in patients with myelodysplastic syndromes and acute myeloid leukemia: A meta‐analysis	8
The therapeutic effects of berberine for gastrointestinal cancers	8
Enkurin domain containing 1 (ENKD1) regulates the proliferation, migration and invasion of non‐small cell lung cancer cells	8

Dynamic changes in systemic immune‐inflammation index predict pathological tumor response and overall survival in patients with gastric or gastroesophageal junction cancer receiving neoadjuvant chemot	8
Cyclophosphamide‐induced cardiotoxicity at conditioning for allogeneic hematopoietic stem cell transplantation would occur among the patients treated with 120 mg/kg or less	8
Nomogram based on the systemic immune‐inflammation index for predicting the prognosis of diffuse large B‐cell lymphoma	8
Australia and New Zealand's responsibilities in improving oncology services in the Asia‐Pacific: A call to action	7
The pathophysiology and current treatments for the subcutaneous panniculitis‐like T cell lymphoma: An updated review	7
Current status and temporal trend of disease burden of thyroid cancer in China from 1990 to 2019	7
Safety of AS04‐HPV‐16/18 vaccine in Chinese women aged 26 years and older and long‐term protective effect in women vaccinated at age 18–25 years: A 10‐year follow‐up study	7
Conventional supportive cancer care services in Australia: A national service mapping study (The CIA study)	7
Combination chemotherapy with NAB^®‐paclitaxel and capecitabine for patients with advanced biliary tract cancer (NAP‐CAPABIL Pilot Study)	7
The management of HER2‐positive early breast cancer: Current and future therapies	6
Accurate prediction of epidermal growth factor receptor mutation status in early‐stage lung adenocarcinoma, using radiomics and clinical features	6
Combinatorial approach of immuno‐proton therapy in cancer: Rationale and potential impact	6
Telehealth adoption in cancer clinical trials: An Australian perspective	6
Breast cancer treatment‐related arm lymphoedema and morbidity: A 6‐year experience in an Australian tertiary breast centre	6
Prostate cancer management in the era of COVID‐19: Recommendations from the Hong Kong Urological Association and Hong Kong Society of Uro‐oncology	6
Current status and future perspectives on immunotherapy in neoadjuvant therapy of resectable non‐small cell lung cancer	6
A national survey of oncology physiotherapy services for cancer survivors in Australia	6
Prevention of docetaxel‐associated febrile neutropenia with primary granulocyte colony‐stimulating factor in Chinese metastatic hormone‐sensitive and castration‐resistant prostate cancer patients	6
Teletrials, the new norm? Expert recommendations for teletrials into the future: Findings from the Clinical Oncology Society of Australia Clinical Trial Research Professionals Group Workshop	6
Opinions and strategies of Australian health professionals on tackling cancer‐related financial toxicity: A nationwide survey	6
Terminal differentiation of bone marrow NK cells and increased circulation of TIGIT⁺ NK cells may be related to poor outcome in acute myeloid leukemia	6
Drug‐eluting bead transarterial chemoembolization with medium‐sized versus small‐sized CalliSpheres microspheres in unresectable primary liver cancer	6
TYK2 is a prognostic biomarker and associated with immune infiltration in the lung adenocarcinoma microenvironment	6
Phagocytosis checkpoints on hematopoietic stem cells in patients with myelodysplastic syndromes	5
Efficacy and safety of blinatumomab: Post hoc pooled analysis in Asian adults with relapsed/refractory B‐cell precursor acute lymphoblastic leukemia	5
Comparison between flattening filter‐free (FFF) and flattened photon beam VMAT plans for the whole brain radiotherapy (WBRT) with hippocampus sparing	5
Poster Abstracts	5
Evaluation of a mainstream genetic testing program for women with ovarian or breast cancer	5
The role of combining immunotherapy with primary (Chemo)radiotherapy in curative treatment settings of the head and neck cancer	5
Managing advanced prostate cancer in the Asia Pacific region: “Real‐world” application of Advanced Prostate Cancer Consensus Conference 2019 statements	5
Beyond cabazitaxel: Late line treatments in metastatic castration resistant prostate cancer: A retrospective multicentre analysis	5
Performance status as prognostic factor in phase III trials of first‐line chemotherapy of unresectable or metastatic pancreatic cancer: A trial‐level meta‐analysis	5
Oxycodone/naloxone prolonged‐release tablets in patients with moderate‐to‐severe, chronic cancer pain: Challenges in the context of hepatic impairment	5
Incidence, survival and stage at diagnosis of small intestinal neuroendocrine tumours in Queensland, Australia, 2001‐2015	5
Molecular basis and targeted therapies for radioiodine refractory thyroid cancer	5
Psoas muscle depletion during preoperative chemotherapy for advanced gastric cancer has a negative impact on long‐term outcomes after gastrectomy	5
Long‐term clinical outcomes of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy using the CyberKnife^® robotic radiosurgery system for vestibular schwannoma	5
Lung cancer treatment patterns and factors relating to systemic therapy use in Australia	5
A phase I study of LCL161, a novel oral pan‐inhibitor of apoptosis protein (IAP) antagonist, in Japanese patients with advanced solid tumors	5
The role of postoperative radiotherapy after primary tumor resection in patients with de novo stage IV breast cancer	5
Physalin B inhibits cell proliferation and induces apoptosis in undifferentiated human gastric cancer HGC‐27 cells	5
Clinical application of preserving spontaneous breathing non‐intubation anesthesia in thoracoscopic surgery for lung cancer under ERAS concept	5
Referral and uptake of services by distressed callers to the Cancer Council Information and Support telephone service	5
The national trend of the gastric cancer burden in Iran from 1990 to 2017	5
Preoperative docetaxel, cisplatin, and fluorouracil treatment with pegfilgrastim on day 7 for patients with esophageal cancer: A phase II study	5
Opportunities and barriers for the use of Australian cancer registries as platforms for randomized clinical trials	5
Review of systemic chemotherapy in unresectable colorectal peritoneal carcinomatosis	5
Combination of hyperthermia and intravesical chemotherapy for the treatment of pT1 stage bladder cancer: A retrospectively clinical study	4
Early phase oncology clinical trials in Malaysia: current status and future perspectives	4
Frequency of germline BRCA1/2 mutations and association with clinicopathological characteristics in Turkish women with epithelial ovarian cancer	4

Early administration of durvalumab after chemoradiotherapy increased risk of pneumonitis in patients with locally advanced non‐small cell lung cancer	4
Prevention and management of acneiform rash associated with EGFR inhibitor therapy: A systematic review and meta‐analysis	4
miR‐425 regulates ovarian cancer proliferation, metastasis, and apoptosis by repressing PAK4 expression	4
Loss of adipose tissue or skeletal muscle during first‐line gemcitabine/nab‐paclitaxel therapy is associated with worse survival after second‐line therapy of advanced pancreatic cancer	4
Clinical evidence and insights supporting the use of avelumab first‐line maintenance treatment in patients with advanced urothelial carcinoma in the Asia‐Pacific region	4
Longitudinal study of intravenous versus subcutaneous immunoglobulin replacement therapy in hematological malignancy	4
Polysaccharide of Lactobacillus casei SB27 reduced colon cancer cell prognosis through mitochondrial damage by upregulation of HINT2	4
Clinical features and long‐term outcomes of aggressive fibromatosis of the abdominal wall after surgical resection: A retrospective study and literature review	4
Toxicity profile of patients treated with proton and carbon‐ion therapy for primary nasopharyngeal carcinoma: A systematic review and meta‐analysis	4
A prospective phase II study of raltitrexed combined with S‐1 as salvage treatment for patients with refractory metastatic colorectal cancer	4
Implementation and evaluation of a smoking cessation checklist implemented within Australian cancer services	4
Low‐frequency ultrasound combined with microbubbles improves gene transfection in prostate cancer cells in vitro and in vivo	4
Docetaxel and cisplatin induction chemotherapy with or without fluorouracil in locoregionally advanced nasopharyngeal carcinoma: A retrospective propensity score matching analysis	4
Population pharmacokinetics of doxorubicin: A systematic review	4
Reliability and validity of the Cancer Health Literacy Test – Chinese versions: CHLT‐30‐Chinese and CHLT‐6‐Chinese	4
Dismal outcome of relapsed or primary refractory adult T‐cell lymphoblastic lymphoma: A retrospective study from China	4
Upregulation of O‐GlcNAc transferase is involved in the pathogenesis of acute myeloid leukemia	4
Pediatric hemophagocytic lymphohistiocytosis in a tropical country: Results of a multicenter study in Thailand	4
Barriers and potential solutions to international collaboration in neuro‐oncology clinical trials: Challenges from the Australian perspective	4
Clinical management of stage III non‐small cell lung cancer in India: An expert consensus statement	3
Current status of total neoadjuvant therapy for locally advanced rectal cancer	3
Differences in lesion interpretation between radiologists in two countries: Lessons from a digital breast tomosynthesis training test set	3
Optimizing care for younger women with hormone receptor‐positive, HER2‐negative metastatic breast cancer	3
Local ablative radiotherapy on oligo‐progression while continued on epidermal growth factor receptor tyrosine kinase inhibitors in advanced non–small cell lung cancer patients: A longer cohort	3
The influence of transarterial chemoembolization on serum levels of soluble programed cell death ligand‐1 in advanced hepatocellular carcinoma patients	3
Impact of age on outcomes in young women with breast cancer	3
	3
Stereotactic body radiotherapy prolongs the progression‐free survival and delays the change of systemic therapy regimen in patients with lung oligoprogressive metastatic colorectal cancer	3
Autoimmune polyendocrine syndrome type 3, characterized by autoimmune thyroid disease, type 1 diabetes mellitus, and isolated ACTH deficiency, developed during adjuvant nivolumab treatment	3
Clinical results of total en bloc spondylectomy using a single posterior approach in spinal metastasis patients: Experiences from Thailand	3
The clinical features, treatment, and prognostic factors for peripheral T‐cell lymphomas: A single‐institution analysis of 240 Chinese patients	3
Molecular characteristics of young‐onset colorectal cancer in Vietnamese patients	3
Olaparib maintenance monotherapy in Chinese patients with platinum‐sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trial	3
Role of stereotactic body radiotherapy for early‐stage non‐small‐cell lung cancer in patients borderline for surgery due to impaired pulmonary function	3
Patient demographics and management landscape of metastatic colorectal cancer in the third‐line setting: Real‐world data in an australian population	3
Asbestos‐related lung cancer: Clinical characteristics and survival outcomes in an Australian cohort seeking workers compensation	3
Bladder filling volume variation between the first and second day of planning computed tomography for prostate cancer radiation therapy and correlation with renal function	3
Disulfiram‐copper activates chloride currents and induces apoptosis with tyrosine kinase in prostate cancer cells	3
Early cancer cachexia phenotype predicts survival of advanced urothelial cancer patients treated with pembrolizumab	3
	3
Physical activity behaviors in cancer survivors treated with neurotoxic chemotherapy	3
MDM4 polymorphisms associated with the risk but not the prognosis of esophageal cancer in Cixian high‐incidence region from northern China	3
Safety and potential increased risk of toxicity of radiotherapy combined immunotherapy strategy	3
	3
Olaparib dose re‐escalation in ovarian cancer patients who experienced severe and/or uncommon adverse events: A case series	3
3D‐T2W‐TSE radiotherapy treatment planning MRI using compressed sensing acceleration for prostate cancer: Image quality and delineation value	3
Systemic treatment of advanced and metastatic urothelial cancer: The landscape in Australia	3
Re‐evaluation of the prognostic significance of retropharyngeal node metastasis in nasopharyngeal carcinoma patients treated with intensity‐modulated radiotherapy	3
Clinical and molecular profile of young adults with early‐onset colorectal cancer: Experience from four Australian tertiary centers	3
Experiences and perspectives of cancer stakeholders regarding COVID‐19 vaccination	3
Evaluation of cytogenetic response in CML patients with variant Philadelphia translocation	3
CD151 and prostate cancer progression: A review of current literature	3
Glucose to lymphocyte ratio predicts prognoses in patients with colorectal cancer	3
Efficacy, toxicity, and quality‐of‐life outcomes of ultrahypofractionated radiotherapy in patients with localized prostate cancer: A single‐arm phase 2 trial from Asia	3
Liver resection for large and huge hepatocellular carcinoma: Predictors of failure, recurrence patterns, and prognoses	3
Oral Abstracts	3
Incidence and appropriate management of drug‐induced interstitial lung disease in Japanese patients with unresectable pancreatic cancer: A multicenter retrospective study	3
Role of β1‐integrin in promoting cell motility and tamoxifen resistance of human breast cancer MCF‐7 cells	3
Perceived importance of emotional support provided by health care professionals and social networks: Should we broaden our focus for the delivery of supportive care?	3
Clinical and biochemical predictors of tumor response after neoadjuvant therapy in rectal cancer	3
Resilience and ongoing quality care for cancer clinical trials during COVID‐19: Experience from a tertiary hospital in Australia	3
Discordance between clinical and pathologic staging and the timeliness of care of non‐small cell lung cancer patients diagnosed with operable tumors	3
	3
The management of clinically suspicious para‐aortic lymph node metastasis in colorectal cancer: A systematic review	3
Centralization and prospective audit of cystectomy are necessary: a commentary on the case for centralization, supported by a contemporary series utilizing the ANZUP cystectomy database	2
Incorporation of eribulin in the systemic treatment of metastatic breast cancer patients in Australia	2
Comparison of weekly methotrexate regimen versus methotrexate folinic acid 8‐day regimen for treatment of low‐risk gestational trophoblastic neoplasia	2
Association between deficient levels of circulating vitamin D, dietary intake of vitamin D, calcium and retinol, and risk of colorectal cancer in an Iranian population: A case control study	2
Communication and collaboration skills training in Radiation Oncology in Australia and New Zealand: A qualitative study	2
Consensus statements on the management of metastatic renal cell carcinoma from the Hong Kong Urological Association and the Hong Kong Society of Uro‐Oncology 2019	2
Cancer survivors’ exercise beliefs, knowledge, and behaviors: An Australian National Survey	2
Indonesian consensus on systemic therapies for hepatocellular carcinoma	2
Management of lateral pelvic lymph nodes by Australasian colorectal surgeons: An insight from the west	2
Overcoming the impact of the COVID‐19 pandemic on oncology early phase trials and drug development in Asia—Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium	2
The role of bile acid subtypes in the diagnosis of cholangiocarcinoma	2
Clinical Oncology Society of Australia Position Statement: 2022 update to the safe handling of monoclonal antibodies in healthcare settings	2
Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australasian population	2
To biopsy or not to biopsy? Outcomes following stereotactic body radiotherapy (SBRT) for biopsy‐confirmed versus radiologically‐diagnosed primary lung cancer in a single Australian institution	2
Rates of adherence to cancer treatment guidelines in Australia and the factors associated with adherence: A systematic review	2
PD‐L1 heterogeneity in patients with non–small cell lung cancer	2

Effect of diabetes mellitus comorbidity on outcomes in stages II and III colorectal cancer	2
Exercise recommendations and referral patterns of oncology professionals	2
Associations of body mass index and weight change with circulating levels of high‐sensitivity C‐reactive protein, proinflammatory cytokines, and adiponectin among breast cancer survivors	2
Factors beyond diagnosis and treatment that are associated with return to work in Australian cancer survivors—A systematic review	2
Life‐threatening infections during treatment for acute lymphoblastic leukemia on the Malaysia‐Singapore 2003 and 2010 clinical trials: A risk prediction model	2
Influence of EGFR mutation status and PD‐L1 expression in stage III unresectable non‐small cell lung cancer treated with chemoradiation and consolidation durvalumab	2
Dilemma and solutions of treatment delay in cancer patients during the COVID‐19 pandemic: A single‐center, prospective survey	2
If we build it, will they come? Modeling of public hospital care requirements for the Australian Bragg Centre for Proton Therapy and Research	2
New Zealand national retrospective cohort study of survival outcomes of patients with metastatic melanoma receiving immune‐checkpoint inhibitors	2
Measurement that matters: A systematic review and modified Delphi of multidisciplinary colorectal cancer quality indicators	2
Is exercise really safe, feasible, and effective for all people diagnosed with cancer?	2
The IHC4+C score: an affordable and reproducible non‐molecular decision‐aid in hormone receptor‐positive breast cancer. Does it still hold value for patients in 2020?	2
⁶⁸Ga‐prostate‐specific membrane antigen (PSMA) PET/CT as a clinical decision‐making tool in biochemically recurrent prostate cancer	2
What affects the public healthcare costs of breast cancer in New Zealand?	2
Attitudes of Australian breast cancer patients toward the secondary use of administrative and clinical trial data	2
Selective internal radiation therapy with yttrium‐90 resin microspheres followed by anatomical hepatectomy: A potential curative strategy in advanced hepatocellular carcinoma	2
Functional results and feasibility of a teleprehabilitation program in patients who are candidates for elective colorectal cancer surgery during the COVID‐19 pandemic	2
Hemophagocytic lymphohistiocytosis (HLH) and cytokine release syndrome (CRS) in a patient with oncogene‐addicted metastatic non‐small cell lung cancer (NSCLC) following combination chemotherapy‐immuno	2
Loss of CDX‐2 expression is an independent poor prognostic biomarker in patients with early‐stage deficient mismatch repair colorectal cancer	2
Maintenance chemotherapy in advanced and metastatic pancreatic cancer, a narrative review and case series	2
The prognostic significance of immune checkpoint receptor expression in patients with lymphoma: Association with disease status and clinical outcomes	2
Resection arthrodesis and osteoarticular allografts reconstruction after resection of primary bone tumors around the knee: Long‐term clinical outcomes and prognostic factors for failure of biological	2
Real‐time image‐guided indocyanine green fluorescence dual‐visualization technique to measure the intraoperative resection margin during thoracoscopic segmentectomy	2
Hong Kong Urological Association–Hong Kong Society of Uro‐Oncology consensus statements on the management of advanced prostate cancer—2019 Updates	2
Impact of neoadjuvant systemic chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal adenocarcinoma	2
The shifting epidemiology of lung cancer in Asian and Asian diaspora populations: Implications for clinical and global health policy research	2
Clinical outcomes after positron emission tomography/computed tomography‐based image‐guided brachytherapy for cervical cancer	2
Incidence, prevalence, and survival trends for neuroendocrine neoplasms in Victoria, Australia, from 1982 to 2019: Based on site, grade, and region	2
Consumers’ experiences, preferences, and perceptions of effectiveness in using telehealth for cancer care in Australia	2
A prospective observational cohort study examining the development of head and neck lymphedema from the time of diagnosis	2
Transitional changes of spacer materials used in carbon‐ion radiation therapy	2
Oral Abstracts	2
Local thermal ablative therapies for extracranial oligometastatic disease of non‐small‐cell lung cancer	2
Safety and efficacy of high‐dose cytarabine MEAM therapy and other treatments for auto‐peripheral blood stem cell transplantation: A retrospective comparative study	2
Poster Abstracts	2
Diagnostic efficacy of combining diffusion‐weighted magnetic resonance imaging with serum Mucin 1, Mucin 13, and Mucin 16 in distinguishing borderline from malignant epithelial ovarian tumors	2
The molecular characteristics of non‐small cell lung cancer in the Northern Territory's Top End	2
Neo‐adjuvant FOLFIRINOX in borderline resectable and locally advanced pancreatic adenocarcinoma	1
Noninferior oncological outcomes in adults aged 80 years or older compared with younger patients who underwent radical nephroureterectomy for upper tract urothelial carcinoma	1
Suitability of endobronchial ultrasound‐guided transbronchial needle aspiration samples for programmed death ligand‐1 testing in non‐small cell lung cancer, the Bristol experience	1
The systemic management of central nervous system metastases and leptomeningeal disease from advanced lung, melanoma, and breast cancer with molecular drivers: An Australian perspective	1
Issue Information	1
TNM classification of malignant tumors: Eighth edition for retroperitoneal liposarcoma. Ways to improve	1
Surgical management of breast cancer in Victoria: A state‐wide audit	1
eviQ Cancer Treatments Online: Providing evidence‐based information to improve cancer patient outcomes	1
Prospective, open‐label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE study	1
Construction and validation of a novel tumor necrosis factor‐related apoptosis‐inducing ligand mutant MuR5S4‐TR	1
Exosome miR‐3184‐5p inhibits gastric cancer growth by targeting XBP1 to regulate the AKT, STAT3, and IRE1 signalling pathways	1
The role of surveillance imaging for resected high‐risk melanoma	1
Development and validation of Join Clinical Trial Questionnaire (JoinCT)	1
Poster Abstracts	1
Taxane‐induced neuropathy: How serious is this problem for patients with early breast cancer?	1
	1
Clinical significance and prognostic value of circulating B10 cells in colorectal cancer	1
Trainee Oral Presentation Abstracts	1
Current landscape of cancer survivorship research in Australia	1
Treatment outcomes of patients with involved resection margin after rectal cancer surgery: A nationwide population‐based cohort study in South Korea	1
T‐cell lymphoma patient harboring BCL11B mutations had favorable overall survival	1
Liquid biopsy in non‐small cell lung cancer: Is it ready for prime time yet?	1
A prospective study of diagnostic accuracy of multidisciplinary team and radiology reporting of preoperative colorectal cancer local staging	1
Does the number of cycles of neoadjuvant therapy affect the efficacy of neoadjuvant chemoimmunotherapy for non‐small cell lung cancer in locally advanced stage? Retrospective experience based on a sin	1
External validation of the American Joint Committee on Cancer melanoma staging system eighth edition using the surveillance, epidemiology, and end results program	1
	1
Patterns of curative treatment for non‐small cell lung cancer in New South Wales, Australia	1
Participation in oral health screening among cancer survivors	1
Real‐world evidence of cisplatin versus carboplatin in patients with locally advanced nasopharyngeal carcinoma receiving concurrent chemoradiotherapy: A multicenter analysis	1
Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma: Does the sequence matter?	1
Breast conservation versus mastectomy for metaplastic breast cancer: A systematic review and meta‐analysis	1
Malignant pericardial effusions: A retrospective look at etiology and prognosis in a tertiary oncological center	1
Oncological outcomes for encapsulated papillary carcinoma of the breast: Multicentric study of Turkish Society for Radiation Oncology breast cancer study group (TROD 06–014 study)	1
Retrospective review of safety and efficacy of anlotinib in advanced osteosarcoma with metastases after failure of standard multimodal therapy	1
Palbociclib plus letrozole as treatment for postmenopausal women with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer for whom letrozole therapy is d	1
The impact of multidisciplinary cancer meetings in guiding treatment intent in patients with upper tract urothelial carcinoma	1
Evaluation of molecular methods for plasma detection of EGFR mutations in non‐small cell lung cancer	1
Poster Abstracts	1
Asia‐Pacific Leukemia Consortium: An innovative and collaborative initiative to improve care of leukemia and related diseases in the Asia‐Pacific region	1
Clinical course of patients with renal cell carcinoma or urothelial carcinoma who had stable disease as an initial response to a PD‐1 or PD‐L1 inhibitor	1
Established the prediction model of early‐stage non‐small cell lung cancer spread through air spaces (STAS) by radiomics and genomics features	1
POSTER LISTING	1
Clinical outcomes of image‐guided percutaneous drainage of pericardial effusion in cancer patients: A single‐center retrospective analysis	1
Real‐world management and patient perspectives on QOL with neuroendocrine tumors: An ANZ perspective	1
Comparison of antibody response to coronavirus disease 2019 vaccination between patients with solid or hematologic cancer patients undergoing chemotherapy	1
Clinical outcomes and prognostic factors of cone‐beam CT‐guided radiofrequency ablation for pulmonary metastases in colorectal cancer patients	1
Prognostic markers including immune and inflammatory factors predict outcomes in patients receiving postoperative radiation therapy for cholangiocarcinoma	1
Radioimmunotherapy with ¹³¹I‐rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma	1
Controlling nutritional status score in predicting International Society of Urological Pathology score upgrading and biochemical recurrence after radical prostatectomy	1
Impact of incorporating Magnetic Resonance Imaging in FIGO Staging of Primary Carcinoma Cervix: Experience from a tertiary cancer center	1
Managing patients with advanced soft tissue sarcoma: Evolving landscape from an Australian perspective	1
Management of rectal cancer in the era of total neoadjuvant therapy and watch and wait: A multidisciplinary team discussion at the Australasian Gastro‐Intestinal Trials Group (AGITG) Annual Scientific	1
Efficacy evaluation of different measurement methods for target lesions after neoadjuvant chemotherapy and radical radiotherapy in locally advanced hypopharyngeal carcinoma	1
	1
Gail model and fifth edition of ultrasound BI‐RADS help predict axillary lymph node metastasis in breast cancer—A multicenter prospective study	1
Overdiagnosis and overtreatment of ground‐glass nodule‐like lung cancer	1
Development and pilot‐testing of the expanded prostate index composite – Filipino version (EPIC‐F)	1
Phase 1 trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study)	1